Search research articles
Contact Us
Filters
Showing results (61-70 of 106) with videos related to
Page
of 11
Sort By:
Neurology
|
July 14, 2004
Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment
M P Amato, M L Bartolozzi, V Zipoli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 1, 2007
The Rao's Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population
M P Amato, E Portaccio, B Goretti, et al.
European Journal of Neurology
|
February 22, 2017
Effect of organizational features on patient satisfaction with care in Italian multiple sclerosis centres
K Mattarozzi, E Baldin, C Zenesini, et al.
Brain Imaging and Behavior
|
October 9, 2020
Peak width of skeletonized mean diffusivity (PSMD) and cognitive functions in relapsing-remitting multiple sclerosis
C Vinciguerra, A Giorgio, J Zhang, et al.
Neurology
|
January 21, 2012
Association of MRI metrics and cognitive impairment in radiologically isolated syndromes
M P Amato, B Hakiki, B Goretti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
March 17, 2011
Multiple sclerosis in Italy: cost-of-illness study
F Patti, M P Amato, M Trojano, et al.
Neurology
|
July 31, 2009
Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis
E Portaccio, M L Stromillo, B Goretti, et al.
Neurology
|
August 30, 2008
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis
M P Amato, E Portaccio, M L Stromillo, et al.
Neurology
|
September 15, 2004
The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study
C Solaro, G Brichetto, M P Amato, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 10, 2009
Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis
F Patti, M P Amato, S Bastianello, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 106) with videos related to
Sort By:
Page
of 11
Neurology
|
July 14, 2004
Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment
M P Amato, M L Bartolozzi, V Zipoli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 1, 2007
The Rao's Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population
M P Amato, E Portaccio, B Goretti, et al.
European Journal of Neurology
|
February 22, 2017
Effect of organizational features on patient satisfaction with care in Italian multiple sclerosis centres
K Mattarozzi, E Baldin, C Zenesini, et al.
Brain Imaging and Behavior
|
October 9, 2020
Peak width of skeletonized mean diffusivity (PSMD) and cognitive functions in relapsing-remitting multiple sclerosis
C Vinciguerra, A Giorgio, J Zhang, et al.
Neurology
|
January 21, 2012
Association of MRI metrics and cognitive impairment in radiologically isolated syndromes
M P Amato, B Hakiki, B Goretti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
March 17, 2011
Multiple sclerosis in Italy: cost-of-illness study
F Patti, M P Amato, M Trojano, et al.
Neurology
|
July 31, 2009
Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis
E Portaccio, M L Stromillo, B Goretti, et al.
Neurology
|
August 30, 2008
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis
M P Amato, E Portaccio, M L Stromillo, et al.
Neurology
|
September 15, 2004
The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study
C Solaro, G Brichetto, M P Amato, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 10, 2009
Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis
F Patti, M P Amato, S Bastianello, et al.
Page
of 11